LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
103.44
-0.30 (-0.29%)
Nov 20, 2024, 4:00 PM EST - Market closed
LeMaitre Vascular Revenue
LeMaitre Vascular had revenue of $54.82M in the quarter ending September 30, 2024, with 15.63% growth. This brings the company's revenue in the last twelve months to $213.03M, up 14.81% year-over-year. In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth.
Revenue (ttm)
$213.03M
Revenue Growth
+14.81%
P/S Ratio
10.87
Revenue / Employee
$338,141
Employees
630
Market Cap
2.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 193.48M | 31.83M | 19.69% |
Dec 31, 2022 | 161.65M | 7.23M | 4.68% |
Dec 31, 2021 | 154.42M | 25.06M | 19.37% |
Dec 31, 2020 | 129.37M | 12.13M | 10.35% |
Dec 31, 2019 | 117.23M | 11.66M | 11.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Ardent Health Partners | 5.71B |
iRhythm Technologies | 560.03M |
Protagonist Therapeutics | 323.80M |
NewAmsterdam Pharma Company | 33.59M |
Geron | 29.48M |
Arrowhead Pharmaceuticals | 19.65M |
IDEAYA Biosciences | 3.92M |
CG Oncology | 684.00K |
LMAT News
- 17 days ago - LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story - Seeking Alpha
- 19 days ago - LeMaitre to Participate at Upcoming Investor Conferences in November - GlobeNewsWire
- 20 days ago - LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - LeMaitre Q3 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 - GlobeNewsWire
- 3 months ago - LeMaitre to Participate at Upcoming Investor Conferences in September - GlobeNewsWire
- 3 months ago - LeMaitre Vascular, Inc. (LMAT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LeMaitre Q2 2024 Financial Results - GlobeNewsWire